Expanded Access to ABBV-CLS-484

Conditions

• Advanced Solid Tumor Cancer

Eligibility Criteria

Sex

All

Age

N/A - N/A

Healthy Volunteers

Not accepted

Interventions

• DRUG: ABBV-CLS-484 — DRUG

Study Details

This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-CLS-484 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.

Key Dates

Status verified

Dec 2023

Central Contacts

• ABBVIE CALL CENTER
  847.283.8955
  [email protected]

Related Studies

• X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
  PHASE1 · Recruiting · Immunolight, LLC · Washington D.C., District of Columbia
• Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
  PHASE1 · Recruiting · Calico Life Sciences LLC · Tucson, Arizona
• The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
  Recruiting · University of Colorado, Boulder · Aurora, Colorado